227 related articles for article (PubMed ID: 12173118)
21. [Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections].
Zaĭtsev AA
Khirurgiia (Mosk); 2003; (4):51-4. PubMed ID: 12744138
[No Abstract] [Full Text] [Related]
22. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
Madan AK
Clin Ther; 2004 Oct; 26(10):1564-77. PubMed ID: 15598473
[TBL] [Abstract][Full Text] [Related]
23. Fluoroquinolones and anaerobes.
Stein GE; Goldstein EJ
Clin Infect Dis; 2006 Jun; 42(11):1598-607. PubMed ID: 16652318
[TBL] [Abstract][Full Text] [Related]
24. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
Fraise AP
J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of anaerobic septicemia in 26 patients with extensive burn].
Huang X; Ma E; Gong L
Zhonghua Wai Ke Za Zhi; 1995 Dec; 33(12):752-3. PubMed ID: 8762556
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial therapy for anaerobic infections.
Finegold SM
Scand J Gastroenterol Suppl; 1984; 91():61-72. PubMed ID: 6588490
[TBL] [Abstract][Full Text] [Related]
27. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
Iannini PB
Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
[TBL] [Abstract][Full Text] [Related]
28. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial therapy of anaerobic infections, 1991.
Sanders CV; Aldridge KE
Pharmacotherapy; 1991; 11(2 ( Pt 2)):72S-79S. PubMed ID: 2041835
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.
Tomás I; Alvarez M; Limeres J; Otero JL; Saavedra E; López-Meléndez C; Diz P
Oral Microbiol Immunol; 2004 Oct; 19(5):331-5. PubMed ID: 15327647
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.
Goldstein EJ; Citron DM; Vaidya SA; Warren YA; Tyrrell KL; Vreni Merriam C; Fernandez H
Anaerobe; 2006 Apr; 12(2):63-6. PubMed ID: 16701615
[TBL] [Abstract][Full Text] [Related]
32. Carbapenems: a potent class of antibiotics.
Nicolau DP
Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
[TBL] [Abstract][Full Text] [Related]
33. Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy.
Tice AD
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii83-6. PubMed ID: 15150187
[TBL] [Abstract][Full Text] [Related]
34. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP
J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group.
Snydman DR; Jacobus NV; McDermott LA
J Antimicrob Chemother; 2005 Jun; 55(6):1024-8. PubMed ID: 15824092
[TBL] [Abstract][Full Text] [Related]
36. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.
Betriu C; Sánchez A; Palau ML; Gómez M; Picazo JJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2372-4. PubMed ID: 11451700
[TBL] [Abstract][Full Text] [Related]
37. Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.
Wareham DW; Wilks M; Ahmed D; Brazier JS; Millar M
Clin Infect Dis; 2005 Apr; 40(7):e67-8. PubMed ID: 15824978
[TBL] [Abstract][Full Text] [Related]
38. Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.
Papaparaskevas J; Pantazatou A; Katsandri A; Houhoula DP; Legakis NJ; Tsakris A; Avlamis A
J Antimicrob Chemother; 2008 Jul; 62(1):137-41. PubMed ID: 18385145
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
Huelves L; Gracia M; Del Prado G; Rodríguez-Cerrato V; Martínez-Marín C; Ponte C; Soriano F; Coronel P; Gimeno M; Blanco J
Int J Antimicrob Agents; 2006 Aug; 28(2):151-3. PubMed ID: 16815688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
